Yorvipath 168 micrograms/0.56 mL solution for injection in pre filled pen
*Company:
Ascendis Pharma Bone Diseases A/SStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 12 December 2024
File name
SmPC Nov 2024.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 8 - Marketing authorisation number(s)
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 12 December 2024
File name
PIL Nov 2024.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
- Change to section 7 - Instructions for use
Updated on 02 September 2024
File name
yorvipath-epar-product-information_en_SmPC.pdf
Reasons for updating
- Other
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 02 September 2024
File name
yorvipath-epar-product-information_en_PIL.pdf
Reasons for updating
- New PIL for new product
Ascendis Pharma Bone Diseases A/S
Address:
Templar House, 81-87 High Holborn,London,WC1V6DF, Ascendis Pharma Bone Diseases A/S Tuborg Boulevard 12 DK 2900 Hellerup DenmarkMedical Information E-mail:
atke@ascendispharma.comMedical Information Direct Line:
+44 7969 628113